DCGI has also given emergency approval to Bharat Biotech's Covaxin for children between the age group of 6-12 on Tuesday. The drug regulator has also granted emergency use authorisation for Biological E's Covid-19 vaccine Corbevax for those aged five to 12 years.
ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus.
It is also the first Covid vaccine that is needle-free and administered using PharmaJet, a needle-free applicator to ensure painless intradermal vaccine delivery which also leads to a significant reduction in any kind of major side effects.
Whereas Biological E's Corbevax is being used to inoculate children against coronavirus in the age group of 12 to 14 years. Covaxin has been granted Emergency Use Listing (EUL) by the DCGI for the age group of 12 to 18 years on December 24, 2021.